Plurilock Signs US$393,000 Contract for Cybersecurity Solutions Project with California State Critical Infrastructure Agency
Vancouver, British Columbia–(Newsfile Corp. – August 10, 2023) – Plurilock Security Inc. (TSXV: PLUR) (OTCQB:…
Month: August 2023
Reklaim Ltd Announces Record Revenue & Positive Comprehensive Income for Q2-2023 & YTD
With positive operating cash flow for Q2 and YTD, and four consecutive quarters of record…
Sonim Announces Strategic Expansion of Mobile Phone Portfolio for Broader Market Segment; Available from 2024
New line of consumer-centric phones, awarded by two tier-one carriers in North America, addresses market…
Society Pass Inc’s (Nasdaq: SOPA) 2Q/1H 2023 Financial Results Illustrate Continuing Breakneck Revenue Growth and Exceptional Profit Margin Expansion; Confidently Forecasts Achieving Cash Profitability in 2H 2023
New York, Aug 10, 2023 – (ACN Newswire) – Society Pass Incorporated (Nasdaq: SOPA) (“SoPa”),…
Cummins and Chevron Advance Strategic Collaboration
COLUMBUS, Ind. & SAN RAMON, Calif.–(BUSINESS WIRE)–Cummins Inc. (NYSE: CMI) and Chevron U.S.A. Inc., a…
Redfin Report: Low Demand + Lower Supply = High Prices
U.S. home prices are up 3% year over year despite relatively slow demand. That’s due…
Salesloft Welcomes Sam Loveland as Chief Customer Officer
Former customer success executive at ServiceNow, Microsoft, and Salesforce joins Salesloft amid massive company innovation…
Groundbreaking AI-Powered Dermatology Practice Launches in Massachusetts, Meets Unprecedented Demand
The MIT-founded company has been adding hundreds of patients per month since launching BOSTON–(BUSINESS WIRE)–Piction…
Lookout Introduces Gen AI Assistant ‘Lookout SAIL’ to Transform Cybersecurity Operations
Lookout SAIL is designed to empower cyber defenders by leveraging generative AI technology to enhance…
X4 Pharmaceuticals Reports Second-Quarter 2023 Financial Results, Provides Corporate Updates, and Reports Emerging Data from Chronic Neutropenia Clinical Program
Submission of first U.S. New Drug Application for mavorixafor in WHIM syndrome on track for early…
Novo Nordisk to acquire Inversago Pharma to develop new therapies for people living with obesity, diabetes and other serious metabolic diseases
Bagsværd, Denmark and Montreal, Canada, 10 August 2023 – Novo Nordisk A/S and Inversago Pharma…
New UK partnership and research fund aims to tackle infectious diseases
Liverpool School of Tropical Medicine (LSTM) and self-funded charitable medical research organisation, LifeArc, are partnering…
“Set Role Model” for the high-quality and sustainable development of industry, Youran Dairy received the highest rating of MSCI ESG in the upstream dairy industry for its first evaluation
HONG KONG, Aug 10, 2023 – (ACN Newswire) – On the occasion of the World…
Valligent Launches GSE Data Collection Suite to Support Assessment of Property Condition and Eligibility
SANTA ANA, Calif.–(BUSINESS WIRE)–#GSEDataCollectionSuite—Valligent, a Veros Software company, and innovative real estate valuation company, has…
YETI Reports Second Quarter 2023 Results
Net Sales Decreased 4%; Adjusted Net Sales Increased 2% Gross Margin Continues to Expand Raises…
National Vision Holdings, Inc. Reports Second Quarter 2023 Financial Results
Net revenue of $525.3 million, an increase of 3.1% from Q2 2022 Comparable store sales…
Mote Kicks Off Second Biomass to Hydrogen Project in Northern California
The biomass-to-hydrogen startup is partnering with Sacramento Municipal Utility District (SMUD) to expand its operations…
Sosei Heptares and Cancer Research UK Announce the Dosing of the First Patient in a Phase I/IIa Trial with Cancer Immunotherapy Drug HTL0039732
HTL0039732 is a novel EP4 antagonist designed by Sosei Heptares with potential to treat a…
Novo Nordisk’s sales increased by 29% in Danish kroner and by 30% at constant exchange rates to DKK 107.7 billion in the first six months of 2023
Financial report for the period 1 January 2023 to 30 June 2023, 10 August 2023 …
Addex Reports 2023 Half Year and Second Quarter Financial Results and Provides Corporate Update
ADX71149 Phase 2 epilepsy clinical study Cohort 2 continues recruiting following the Independent Interim Review…